Rheological Impact of GBT1118 Cessation in a Sickle Mouse Model.

Kanne, Celeste K; Nebor, Danitza; Pochron, Mira; Oksenberg, Donna; Sheehan, Vivien A

Kanne, Celeste K; Nebor, Danitza; Pochron, Mira; Oksenberg, Donna; Sheehan, Vivien A.

Afiliación

Kanne CK; Aflac Cancer & Blood Disorders Center Children's Healthcare of Atlanta, School of Medicine, Emory University, Atlanta, GA, United States.
Nebor D; Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, United States.
Pochron M; Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, United States.
Oksenberg D; Global Blood Therapeutics, South, San Francisco, CA, United States.
Sheehan VA; Global Blood Therapeutics, South, San Francisco, CA, United States.

Front Physiol ; 12: 742784, 2021.

Article en En | MEDLINE | ID: mdl-34630162

Palabras clave

GBT1118; deformability; hemorheology; red cell; rheological biomarkers; sickle cell disease; viscosity; voxelotor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Physiol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google